Category Archives: CEO

Home / CEO
2 Posts

Sheldon Lavin moved into the meat industry roughly 43 years ago after a successful career in banking as well as having a consultant company. He became the CEO and chairman of OSI Group and has subsequently transformed the business into an international distributor of food products. The firm is presently the most massive meat and meat related products processor, and they have been in operation since the early seventies. The corporation has an estimated 20,000 employees internationally. Mr. Sheldon boasts of the low turnover of employees, which he ascribes to the family-oriented corporate culture at the company that guarantees their longevity.

Sheldon Lavin first entered into the meat industry in 1970 when he facilitated financing for Otto & Sons. In 1975, Lavin became more engaged with Otto & Sons as searched for more investments abroad. Due to his active involvement in the company, Lavin was appointed as a partner along with the two sons when their father retired from the business. Later, Mr. Sheldon agreed to move into the market on a full-time basis since he was captivated by the culture of the company and the strategies employed by the corporation.

OSI Group started its journey of spreading out across Europe and North America in the 1970s. In the 1980s, it progressed to South America and Taiwan. Subsequently, it expanded to South Africa, Philippines, Japan, China, and Australia. During this time Lavin had attained 100% voting control of the company. Presently, the OSI Group has more than 60 factories in 16 different countries across the globe. Moreover, Sheldon Lavin is an active philanthropist engaged in various charities such as Evans Scholarship Fund, Boys and Girls Clubs of Chicago, Ronald McDonald House Charities, and Jewish United Fund among many others.

On 20th February 2016, Sheldon Lavin got honored by Vision World Academy from India with the Global Visionary Award in an event held in India. This award acknowledges visionaries in various sectors that have achieved their dreams through perseverance and persistence. He received the award during the Academy’s fifth recognition of prominent visionaries.

Moreover, OSI Group has earned other vital awards counting the Globe of Honor Award conferred by the British Safety Council. This award acknowledged firms that have developed unique techniques of downgrading environmental pollution. OSI Group was also positioned as the 66th corporation in the food and beverage market and declared by Forbes as the leading company in the globe. All these honors were made possible due to the impeccable administration of Sheldon.

Read More: www.facebook.com/OSI-Group-106191179472361/

Among the biotech firms based in the United States, Seattle Genetics stands among those that have contributed enormously to the development of cancer therapy drugs. The man behind this institution is Dr. Clay Siegall who is the founder and chief executive officer. Siegall graduated with a degree in Zoology from the University of Maryland. Later, he attended George Washington University and graduated with a Ph.D. in genetics.

 

In a recent interview, Clay Siegall said that the inspiration that led to the start of this institution laid first in his passion. According to him, he always had a particular interest in medicine, and the power technology holds over disease. He always desired to intervene in nature’s course and bring health to those consigned to death by nature. Siegall first interest was in the cancer therapy. It was after a brutal treatment of a relative that drove him to start the research into the disease. He says that the chemotherapy was so brutal that at a point, it caused anemia almost killing the patient. With alternative options offering no help, he resolved to find a better way. Going to this business of research has catapulted him to the person he is today.

 

According to Siegall, there are several ways in which the company makes money. First, it’s through the sale of proprietary drugs. The company does very well on the sale of antibody drug conjugate that is FDA approved. However, the organization also acquires money from production partnerships and licensing of technologies. Alternatively, they have several sources of revenues through which they get money. Clay continues by adding that the company became profitable ten years after the IPO.

 

Among the challenges that Clay faced came in 2000. The capital was depleting faster than the income they generated. They managed by working extra harder. They have a sales staff that do the marketing. Through a lot of interaction, they land the right buyers. Ultimately, it’s through hard work and passion that he achieved

 

Over the years Clay Siegall held several positions in different organizations. At Mirna Therapeutics, he served on the board of directors. The chairman of the institution regarded Siegall Knowledge as invaluable and would benefit the organization. At Ultragenyx, he also held a position on the board of directors. At 40’s he advises aspiring entrepreneurs to commit, interact and work with passion as they are key to prosperity.